Publications

Original Article

Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients

2021

Authors:

Stanton, SE, Gad E, Ramos, E, Corulli LR, Annis, J, Katayama, H, Hamash S and Disis, ML

Journal:

Nature Partner Journals Breast Cancer

Volume:

7(1)

Page:

50

Pubmed:

Original Article

Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways

Antigen Discovery & Vaccines

2021

Authors:

Cecil, D., Park, K H, Curtis, B, Corulli, L, and Disis, ML

Journal:

Journal for Immunotherapy of Cancer

Volume:

9

Page:

Pubmed:

Original Article

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention

Antigen Discovery & Vaccines

2021

Authors:

Lauren R. Corulli, Denise L. Cecil, Ekram Gad, Marlese Koehnlein, Andrew L. Coveler, Jennifer S. Childs, Ronald A. Lubet, and Mary L. Disis

Journal:

Frontiers in Immunology

Volume:

12

Page:

Pubmed:

Original Article

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Clinical Trials

2021

Authors:

John B Liao, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Doreen M Higgins, Jennifer S Childs, Hania N Shakalia, Ron E Swensen, Sasha E Stanton, Anna V Tinker, Tanya A Wahl, Richard G Ancheta, Kathryn F McGonigle, James Y Dai, Mary L Disis, Barbara A Goff

Journal:

Journal for ImmunoTherapy of Cancer

Volume:

9

Page:

Pubmed:

Original Article

Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers

Tumor Microenvironment

2020

Authors:

Disis ML, Corulli LR, Gad EA, Koehnlein MR, Cecil DL, Senter PD, Gardai SJ, Okeley NM.

Journal:

Molecular Cancer theraputics

Volume:

19(5)

Page:

1102-1109

Pubmed:

Original Article

Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer

General Immune Research

2020

Authors:

Fahrmann JF, Vykoukal J, Fleury A, Tripathi S, Dennison JB, Murage E, Wang P, Yu CY, Capello M, Creighton CJ, Do KA, Long JP, Irajizad E, Peterson C, Katayama H, Disis ML, Arun B, Hanash S.

Journal:

Journal of Natural Cancer Institute

Volume:

112(6)

Page:

607-616

Pubmed:

Original Article

Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets

Antigen Discovery & Vaccines

2019

Authors:

Stanton SE, Gad E, Corulli LR, Lu H, Disis ML.

Journal:

Vaccine

Volume:

37(27)

Page:

3552-3561

Pubmed:

Original Article

A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancer

General Immune Research

2019

Authors:

Katayama H, Tsou P, Kobayashi M, Capello M, Wang H, Esteva F, Disis ML, Hanash S.

Journal:

NPJ Precision Oncology

Volume:

3

Page:

10

Pubmed:

Original Article

The Effect of Mouse Strain, Sex, and Carcinogen Dose on Toxicity and the Development of Lung Dysplasia and Squamous Cell Carcinomas in Mice

Animal Models

2019

Authors:

Laura Riolobos, Ekram A. Gad, Piper M. Treuting, Andrew E. Timms, Elliot A. Hershberg, Lauren R. Corulli, Erin Rodmaker and Mary L. Disis

Journal:

Cancer Prevention Research

Volume:

12(8)

Page:

507-16

Pubmed:

Original Article

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial

Clinical Trials

2019

Authors:

Disis ML, Taylor MH, Kelly K, Beck JT, Gordon M, Moore KM, Patel MR, Chaves J, Park H, Mita AC, Hamilton EP, Annunziata CM, Grote HJ, von Heydebreck A, Grewal J, Chand V, Gulley JL.

Journal:

Jama Oncology

Volume:

5(3)

Page:

393-401

Pubmed: